{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T04:52:48Z","timestamp":1790657568557,"version":"4.1.0"},"reference-count":29,"publisher":"Elsevier BV","issue":"33","license":[{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2021,7]]},"DOI":"10.1016\/j.vaccine.2021.06.066","type":"journal-article","created":{"date-parts":[[2021,7,3]],"date-time":"2021-07-03T07:30:25Z","timestamp":1625297425000},"page":"4641-4650","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["AIDSVAX protein boost improves breadth and magnitude of vaccine-induced HIV-1 envelope-specific responses after a 7-year rest period"],"prefix":"10.1016","volume":"39","author":[{"given":"Yunda","family":"Huang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2009-3270","authenticated-orcid":false,"given":"Kelly E.","family":"Seaton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin","family":"Casapia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5476-7632","authenticated-orcid":false,"given":"Laura","family":"Polakowski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen C.","family":"De Rosa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kristen","family":"Cohen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chenchen","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3515-1530","authenticated-orcid":false,"given":"Marnie","family":"Elizaga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8640-6623","authenticated-orcid":false,"given":"Carmen","family":"Paez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4637-1283","authenticated-orcid":false,"given":"Maurine D.","family":"Miner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5611-0119","authenticated-orcid":false,"given":"Colleen F.","family":"Kelley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3992-4193","authenticated-orcid":false,"given":"Janine","family":"Maenza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Keefer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Javier R.","family":"Lama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Magdalena","family":"Sobieszczyk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susan","family":"Buchbinder","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lindsey R.","family":"Baden","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9118-106X","authenticated-orcid":false,"given":"Carter","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vineeta","family":"Gulati","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Faruk","family":"Sinangil","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Montefiori","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M. Juliana","family":"McElrath","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Georgia D.","family":"Tomaras","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Harriet L.","family":"Robinson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul","family":"Goepfert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2021.06.066_b0005","unstructured":"UNAIDS. UNAIDS Data 2019. Available at: Accessed October 29, 2020. https:\/\/www.aidsdatahub.org\/sites\/default\/files\/resource\/unaids-data-2019.pdf."},{"key":"10.1016\/j.vaccine.2021.06.066_b0010","first-page":"8","article-title":"CROI 2019: advances in HIV prevention and plans to end the epidemic","volume":"27","author":"Buchbinder","year":"2019","journal-title":"Top Antivir Med"},{"key":"10.1016\/j.vaccine.2021.06.066_b0015","doi-asserted-by":"crossref","first-page":"413","DOI":"10.3201\/eid2403.171797","article-title":"Ending the HIV\/AIDS Pandemic","volume":"24","author":"Eisinger","year":"2018","journal-title":"Emerg Infect Dis"},{"key":"10.1016\/j.vaccine.2021.06.066_b0020","doi-asserted-by":"crossref","first-page":"1881","DOI":"10.1016\/S0140-6736(08)61591-3","article-title":"Efficacy assessment of a cell-mediated immunity HIV-1 vaccine (the Step Study): a double-blind, randomised, placebo-controlled, test-of-concept trial","volume":"372","author":"Buchbinder","year":"2008","journal-title":"Lancet"},{"key":"10.1016\/j.vaccine.2021.06.066_b0025","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1086\/428404","article-title":"Placebo-controlled phase 3 trial of a recombinant glycoprotein 120 vaccine to prevent HIV-1 infection","volume":"191","author":"Flynn","year":"2005","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2021.06.066_b0030","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1016\/S1473-3099(11)70098-6","article-title":"Safety and efficacy of the HVTN 503\/Phambili study of a clade-B-based HIV-1 vaccine in South Africa: a double-blind, randomised, placebo-controlled test-of-concept phase 2b study","volume":"11","author":"Gray","year":"2011","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.vaccine.2021.06.066_b0035","doi-asserted-by":"crossref","first-page":"2083","DOI":"10.1056\/NEJMoa1310566","article-title":"Efficacy trial of a DNA\/rAd5 HIV-1 preventive vaccine","volume":"369","author":"Hammer","year":"2013","journal-title":"N Engl J Med"},{"key":"10.1016\/j.vaccine.2021.06.066_b0040","doi-asserted-by":"crossref","first-page":"1160","DOI":"10.1097\/01.qai.0000136091.72955.4b","article-title":"Phase I\/II study of a candidate vaccine designed against the B and E subtypes of HIV-1","volume":"37","author":"Pitisuttithum","year":"2004","journal-title":"J Acquir Immune Defic Syndr"},{"key":"10.1016\/j.vaccine.2021.06.066_b0045","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.1093\/infdis\/jix099","article-title":"Randomized, Double-Blind Evaluation of Late Boost Strategies for HIV-Uninfected Vaccine Recipients in the RV144 HIV Vaccine Efficacy Trial","volume":"215","author":"Rerks-Ngarm","year":"2017","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2021.06.066_b0050","doi-asserted-by":"crossref","first-page":"2209","DOI":"10.1056\/NEJMoa0908492","article-title":"Vaccination with ALVAC and AIDSVAX to prevent HIV-1 infection in Thailand","volume":"361","author":"Rerks-Ngarm","year":"2009","journal-title":"N Engl J Med"},{"key":"10.1016\/j.vaccine.2021.06.066_b0055","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.1056\/NEJMoa1113425","article-title":"Immune-correlates analysis of an HIV-1 vaccine efficacy trial","volume":"366","author":"Haynes","year":"2012","journal-title":"N Engl J Med"},{"key":"10.1016\/j.vaccine.2021.06.066_b0060","doi-asserted-by":"crossref","first-page":"4838","DOI":"10.1172\/JCI126391","article-title":"Antibody Fc effector functions and IgG3 associate with decreased HIV-1 risk","volume":"129","author":"Neidich","year":"2019","journal-title":"J Clin Invest"},{"key":"10.1016\/j.vaccine.2021.06.066_b0065","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1093\/infdis\/jiq105","article-title":"Phase 1 safety and immunogenicity testing of DNA and recombinant modified vaccinia Ankara vaccines expressing HIV-1 virus-like particles","volume":"203","author":"Goepfert","year":"2011","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2021.06.066_b0070","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1093\/infdis\/jiu003","article-title":"Specificity and 6-month durability of immune responses induced by DNA and recombinant modified vaccinia Ankara vaccines expressing HIV-1 virus-like particles","volume":"210","author":"Goepfert","year":"2014","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2021.06.066_b0075","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0179597","article-title":"Immunogenicity of a novel Clade B HIV-1 vaccine combination: Results of phase 1 randomized placebo controlled trial of an HIV-1 GM-CSF-expressing DNA prime with a modified vaccinia Ankara vaccine boost in healthy HIV-1 uninfected adults","volume":"12","author":"Buchbinder","year":"2017","journal-title":"PLoS ONE"},{"key":"10.1016\/j.vaccine.2021.06.066_b0080","doi-asserted-by":"crossref","first-page":"12449","DOI":"10.1128\/JVI.01708-08","article-title":"Initial B-cell responses to transmitted human immunodeficiency virus type 1: virion-binding immunoglobulin M (IgM) and IgG antibodies followed by plasma anti-gp41 antibodies with ineffective control of initial viremia","volume":"82","author":"Tomaras","year":"2008","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2021.06.066_b0085","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0101863","article-title":"HIV-1 specific IgA detected in vaginal secretions of HIV uninfected women participating in a microbicide trial in Southern Africa are primarily directed toward gp120 and gp140 specificities","volume":"9","author":"Seaton","year":"2014","journal-title":"PLoS ONE"},{"key":"10.1016\/j.vaccine.2021.06.066_b0090","doi-asserted-by":"crossref","first-page":"228ra39","DOI":"10.1126\/scitranslmed.3007730","article-title":"Vaccine-induced Env V1\u2013V2 IgG3 correlates with lower HIV-1 infection risk and declines soon after vaccination","volume":"6","author":"Yates","year":"2014","journal-title":"Sci Transl Med"},{"key":"10.1016\/j.vaccine.2021.06.066_b0095","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.jim.2007.03.002","article-title":"Optimization and validation of an 8-color intracellular cytokine staining (ICS) assay to quantify antigen-specific T cells induced by vaccination","volume":"323","author":"Horton","year":"2007","journal-title":"J Immunol Meth"},{"key":"10.1016\/j.vaccine.2021.06.066_b0100","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1111\/j.2517-6161.1995.tb02031.x","article-title":"Controlling the false discovery rate: a practical and powerful approach to multiple testing","volume":"57","author":"Benjamini","year":"1995","journal-title":"J Royal Statistical Soc Series B"},{"key":"10.1016\/j.vaccine.2021.06.066_b0105","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1198\/sbr.2009.0008","article-title":"Simultaneous Evaluation of the Magnitude and Breadth of a Left and Right Censored Multivariate Response, with Application to HIV Vaccine Development","volume":"1","author":"Huang","year":"2009","journal-title":"Stat Biopharm Res"},{"key":"10.1016\/j.vaccine.2021.06.066_b0110","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1038\/nbt.3187","article-title":"COMPASS identifies T-cell subsets correlated with clinical outcomes","volume":"33","author":"Lin","year":"2015","journal-title":"Nat Biotechnol"},{"key":"10.1016\/j.vaccine.2021.06.066_b0115","doi-asserted-by":"crossref","first-page":"2354","DOI":"10.1126\/science.1070441","article-title":"Diversity considerations in HIV-1 vaccine selection","volume":"296","author":"Gaschen","year":"2002","journal-title":"Science"},{"key":"10.1016\/j.vaccine.2021.06.066_b0120","doi-asserted-by":"crossref","first-page":"1755","DOI":"10.1093\/infdis\/jiz008","article-title":"Rapid Boosting of HIV-1 Neutralizing Antibody Responses in Humans Following a Prolonged Immunologic Rest Period","volume":"219","author":"Spearman","year":"2019","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2021.06.066_b0125","doi-asserted-by":"crossref","first-page":"1678","DOI":"10.1016\/j.vaccine.2019.12.058","article-title":"Persistence of vaccine-elicited immune response up to 14 years post-HIV gp120-NefTat\/AS01B vaccination","volume":"38","author":"Van Der Meeren","year":"2020","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2021.06.066_b0130","doi-asserted-by":"crossref","first-page":"13031","DOI":"10.1038\/s41598-020-69007-w","article-title":"Impact of vaccine type on HIV-1 vaccine elicited antibody durability and B cell gene signature","volume":"10","author":"Palli","year":"2020","journal-title":"Sci Rep"},{"key":"10.1016\/j.vaccine.2021.06.066_b0135","doi-asserted-by":"crossref","first-page":"2439","DOI":"10.1007\/s00705-020-04777-2","article-title":"Review of preventative HIV vaccine clinical trials in South Africa","volume":"165","author":"Laher","year":"2020","journal-title":"Arch Virol"},{"key":"10.1016\/j.vaccine.2021.06.066_b0140","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1056\/NEJMoa2031499","article-title":"Vaccine Efficacy of ALVAC-HIV and Bivalent Subtype C gp120-MF59 in Adults","volume":"384","author":"Gray","year":"2021","journal-title":"N Engl J Med"},{"key":"10.1016\/j.vaccine.2021.06.066_b0145","unstructured":"Janes H. HVTN 702: Next steps for analysis and marker studies. In: HVTN sub-Saharan Africa Regional Meeting. (Cape Town, South Africa)."}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X21008276?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X21008276?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,2]],"date-time":"2025-10-02T10:59:10Z","timestamp":1759402750000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X21008276"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,7]]},"references-count":29,"journal-issue":{"issue":"33","published-print":{"date-parts":[[2021,7]]}},"alternative-id":["S0264410X21008276"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2021.06.066","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2021,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"AIDSVAX protein boost improves breadth and magnitude of vaccine-induced HIV-1 envelope-specific responses after a 7-year rest period","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2021.06.066","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}